PT2088193E - Novo vector vaivém - Google Patents

Novo vector vaivém Download PDF

Info

Publication number
PT2088193E
PT2088193E PT09003552T PT09003552T PT2088193E PT 2088193 E PT2088193 E PT 2088193E PT 09003552 T PT09003552 T PT 09003552T PT 09003552 T PT09003552 T PT 09003552T PT 2088193 E PT2088193 E PT 2088193E
Authority
PT
Portugal
Prior art keywords
escherichia coli
region
shuttle vector
ptb6
expression vector
Prior art date
Application number
PT09003552T
Other languages
English (en)
Inventor
Yasunobu Kano
Yoshinori Hamaji
Minoru Fujimori
Takayuki Sasaki
Kyoko Kohno
Jun Amano
Shun Ichiro Taniguchi
Original Assignee
Anaeropharma Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anaeropharma Science Inc filed Critical Anaeropharma Science Inc
Publication of PT2088193E publication Critical patent/PT2088193E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Structure Of Belt Conveyors (AREA)
  • Variable-Direction Aerials And Aerial Arrays (AREA)
PT09003552T 2004-11-24 2005-11-24 Novo vector vaivém PT2088193E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004339677 2004-11-24

Publications (1)

Publication Number Publication Date
PT2088193E true PT2088193E (pt) 2011-02-24

Family

ID=36498025

Family Applications (1)

Application Number Title Priority Date Filing Date
PT09003552T PT2088193E (pt) 2004-11-24 2005-11-24 Novo vector vaivém

Country Status (13)

Country Link
US (1) US8021653B2 (pt)
EP (2) EP2088193B1 (pt)
JP (1) JP4989231B2 (pt)
KR (1) KR101243662B1 (pt)
CN (1) CN101065482B (pt)
AT (1) ATE495246T1 (pt)
CA (1) CA2586126C (pt)
DE (1) DE602005025946D1 (pt)
DK (1) DK2088193T3 (pt)
ES (1) ES2357372T3 (pt)
PT (1) PT2088193E (pt)
SG (1) SG158077A1 (pt)
WO (1) WO2006057289A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101407975B1 (ko) 2006-05-24 2014-06-17 가부시키가이샤 아네로파마·사이엔스 유전자 수송담체 제작방법
WO2008084115A2 (en) * 2007-01-12 2008-07-17 Actogenix N.V. Lactococcus promoters and uses thereof
US8535939B2 (en) 2010-01-29 2013-09-17 Anaeropharma Science, Inc. Transfection vector
US9730968B2 (en) 2008-04-17 2017-08-15 Anaeropharma Science, Inc. Therapeutic agent for ischemic diseases
PL2274422T3 (pl) 2008-04-17 2017-09-29 Anaeropharma Science, Inc. Wektor ekspresyjny
US10066240B2 (en) 2014-02-14 2018-09-04 Symvivo Corporation Nucleic acid vectors and uses thereof
CN104388419B (zh) * 2014-10-13 2018-01-16 华侨大学 一种高效扩增核酸分子的方法
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
ES2959326T3 (es) * 2015-11-24 2024-02-23 Glaxosmithkline Ip Dev Ltd Líneas celulares estables para producción retroviral
US10450574B2 (en) * 2015-11-24 2019-10-22 Glaxosmithkline Intellectual Property Development Limited Transient transfection method for retroviral production
KR20170068304A (ko) 2015-12-09 2017-06-19 삼성전자주식회사 대장균 및 코마가타에이박터 속 세포에서 복제가능한 벡터, 그를 포함한 세포, 및 그를 이용하는 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63309191A (ja) * 1987-06-09 1988-12-16 Toagosei Chem Ind Co Ltd プラスミドベクタ−
US6110737A (en) 1988-02-02 2000-08-29 The Regents Of The University Of California Human platelet-derived growth factor receptor, type A
JPH05130876A (ja) * 1991-04-10 1993-05-28 Morinaga Milk Ind Co Ltd プラスミドベクター
US6190657B1 (en) 1995-06-07 2001-02-20 Yale University Vectors for the diagnosis and treatment of solid tumors including melanoma
JP3946300B2 (ja) * 1997-03-27 2007-07-18 株式会社ヤクルト本社 ビフィズス菌用シャトルベクター及びビフィズス菌プラスミドの複製タンパク質遺伝子
US6080849A (en) 1997-09-10 2000-06-27 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
JP2002500001A (ja) 1997-09-10 2002-01-08 ヴァイオン ファーマシューティカルズ、インコーポレーテッド 低下した毒性を有する遺伝子改変腫瘍標的化細菌
JPH11285387A (ja) * 1998-04-03 1999-10-19 Tdk Corp 新規なｄｎａ配列及びそれを含むプラスミドベクター
CA2381755A1 (en) 1999-08-26 2001-03-01 Vion Pharmaceuticals, Inc. Compositions and methods for delivery of an agent using attenuated salmonella containing phage
US6962696B1 (en) 1999-10-04 2005-11-08 Vion Pharmaceuticals Inc. Compositions and methods for tumor-targeted delivery of effector molecules
CA2342040C (en) 2000-09-21 2012-07-10 Kyowa Hakko Kogyo Co., Ltd. Anaerobic bacterium as a drug for cancer gene therapy
JP3642755B2 (ja) 2000-09-21 2005-04-27 純 天野 嫌気性菌を用いた遺伝子治療用医薬
DE60226856D1 (de) * 2001-04-20 2008-07-10 Penn State Res Found Verfahren zur manipulation von nukleinsäuren
JP2003235565A (ja) * 2002-02-20 2003-08-26 Yakult Honsha Co Ltd 乳酸菌用シャトルベクター

Also Published As

Publication number Publication date
EP1829963A1 (en) 2007-09-05
CN101065482A (zh) 2007-10-31
KR101243662B1 (ko) 2013-03-14
KR20070107671A (ko) 2007-11-07
US20100129323A1 (en) 2010-05-27
US8021653B2 (en) 2011-09-20
WO2006057289A1 (ja) 2006-06-01
EP2088193B1 (en) 2011-01-12
JPWO2006057289A1 (ja) 2008-06-05
DE602005025946D1 (de) 2011-02-24
EP1829963A4 (en) 2009-01-28
EP2088193A1 (en) 2009-08-12
JP4989231B2 (ja) 2012-08-01
ATE495246T1 (de) 2011-01-15
CA2586126A1 (en) 2006-06-01
CN101065482B (zh) 2011-07-13
SG158077A1 (en) 2010-01-29
ES2357372T3 (es) 2011-04-25
CA2586126C (en) 2016-06-28
DK2088193T3 (da) 2011-02-28

Similar Documents

Publication Publication Date Title
EP1829963A4 (en) NEW SHUTTLE VECTOR
CA2274982A1 (en) New escherichia coli host/vector system based on antibiotic-free selection by complementation of an auxotrophy
WO2006112930A3 (en) Q3 sparc deletion mutant and uses thereof
AP1763A (en) Pulmonary administration of chemically modified insulin
MXPA04005266A (es) Inmunocitocinas con selectividad modulada.
HK1100850A1 (en) Novel brevibacillus choshinensis and process for producing protein with use of the microbe as host
AR033878A1 (es) Clonacion y secuenciamiento de genes de piruvato descarboxilasa (pdc) de bacterias y usos de los mismos
CA2446776A1 (en) Self-containing lactococcus strain
CA2160131A1 (en) New Bacillus Thuringiensis Strains and Their Insecticidal Proteins
WO2000044906A3 (en) GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI)
DK1425037T3 (da) Bakteriel vaccine
NZ507077A (en) A vaccine comprising a bacterium that has an aroC/ompF/ompC combination mutation and optionally a mutation in a fourth gene
IL141984A0 (en) Akt nucleic acids, polypeptides, and uses thereof
Gupta et al. Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis
EP0953641A3 (en) Polynucleotide molecules encoding neospora proteins
IL174645A0 (en) MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES
AU2002364302A1 (en) Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases
WO2003024992A3 (en) HUMAN AND MOUSE β-DEFENSINS, ANTIMICROBIAL PEPTIDES
BR0314255A (pt) Método de preparação de uma queratinase, bacillus recombinante, cultura bacteriana, e, método de preparação de um bacillus recombinante
IL155878A0 (en) Isolated luciferases and the use thereof
Komine et al. Physical map locations of the genes that encode small stable RNAs in Escherichia coli
WO2001034810A3 (en) Genes essential for microbial proliferation
RS70004A (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectin
EP1178052A3 (en) Genes identified as required for proliferation in Escherichia coli
WO2002040511A3 (de) Dna-sequenz und microcin aus escherichia coli stamm dsm 6601